共 84 条
[1]
Siegel RL(2017)Cancer statistics, 2017 CA Cancer J Clin 67 7-30
[2]
Miller KD(2017)Current standards of chemotherapy for pancreatic cancer Clin Ther 39 2125-2134
[3]
Jemal A(2007)National failure to operate on early stage pancreatic cancer Ann Surg 246 173-180
[4]
Saung MT(2012)Survival after resection of pancreatic adenocarcinoma: results from a single institution over three decades Ann Surg Oncol 19 169-175
[5]
Zheng L(2004)A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer N Engl J Med 351 1200-1210
[6]
Bilimoria KY(2013)Adjuvant chemotherapy with gemcitabine and long-term outcomes among patients with resected pancreatic cancer: the CONKO-001 randomized trial JAMA 310 1473-1481
[7]
Bentrem DJ(2012)Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial JAMA 308 147-156
[8]
Ko CY(2016)Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01) Lancet 388 248-257
[9]
Winter JM(2017)Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial Lancet 389 1011-1024
[10]
Brennan MF(1998)The role of diagnostic laparoscopy in pancreatic and periampullary malignancies J Am Coll Surg 186 675-682